ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Updates on lung cancer from WCLC and ESMO 2023

Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC

What's new on ADCs in management of advanced NSCLC

Treatment of metastatic NSCLC without PD-L1 expression and without oncogene addiction

Personalised systemic treatment in advanced prostate cancer

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC

Applying Choosing Wisely in radiation oncology in Africa

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy

Implementation Science: An emerging role for strengthening cancer control efforts in Africa

Implementation of Choosing Wisely in Rwanda, Tanzania and Ghana